Advisor Partners LLC Gilead Sciences, Inc. Transaction History

Advisor Partners LLC

$1.42 Billion
Q2 2022

A detailed history of Advisor Partners LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Advisor Partners LLC holds 26,634 shares of GILD stock, worth $2.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

26,634

Previous 18,740 42.12%

Holding current value

$2.5 Million

Previous $1.11 Million 47.76%

% of portfolio

0.12%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $455,641 - $513,188	7,894 Added 42.12%	26,634 $1.65 Million
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $440,539 - $552,043	-7,606 Reduced 28.87%	18,740 $1.11 Million
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $152,532 - $173,127	2,351 Added 9.8%	26,346 $1.91 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $209,703 - $226,246	3,098 Added 14.83%	23,995 $1.68 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $124,908 - $136,480	1,968 Added 10.4%	20,897 $1.44 Million
Q1 2021 Jun 01, 2021	BUY	$60.0 - $68.46 $132,300 - $150,954	2,205 Added 13.18%	18,929 $1.22 Million
Q4 2020 Feb 17, 2021	SELL	$56.65 - $64.55 $869,917 - $991,229	-15,356 Reduced 47.87%	16,724 $974,000
Q3 2020 Nov 19, 2020	SELL	$62.1 - $78.08 $1.28 Million - $1.6 Million	-20,545 Reduced 39.04%	32,080 $2.03 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $180,198 - $209,244	2,491 Added 4.97%	52,625 $4.05 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $1.16 Million - $1.49 Million	18,566 Added 58.81%	50,134 $3.75 Million
Q4 2019 Jan 24, 2020	SELL	$61.62 - $67.78 $63,715 - $70,084	-1,034 Reduced 3.17%	31,568 $2.02 Million
Q3 2019 Oct 16, 2019	BUY	$62.51 - $69.0 $287,108 - $316,917	4,593 Added 16.4%	32,602 $2.07 Million
Q2 2019 Jul 26, 2019	BUY	$61.87 - $69.38 $345,667 - $387,626	5,587 Added 24.92%	28,009 $1.89 Million
Q1 2019 Apr 23, 2019	BUY	$62.53 - $70.05 $43,583 - $48,824	697 Added 3.21%	22,422 $1.46 Million
Q4 2018 Jan 29, 2019	SELL	$60.54 - $79.0 $328,550 - $428,733	-5,427 Reduced 19.99%	21,725 $1.36 Million
Q3 2018 Nov 06, 2018	BUY	$71.28 - $78.92 $121,104 - $134,085	1,699 Added 6.68%	27,152 $2.1 Million
Q2 2018 Jul 25, 2018	SELL	$64.88 - $75.68 $14,792 - $17,255	-228 Reduced 0.89%	25,453 $1.8 Million
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $97,022 - $118,281	1,332 Added 5.47%	25,681 $1.94 Million
Q4 2017 Jan 26, 2018	BUY	$71.15 - $83.52 $148,347 - $174,139	2,085 Added 9.36%	24,349 $1.97 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $1.61 Million - $1.9 Million	22,264	22,264 $1.8 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Account

Advisor Partners LLC Gilead Sciences, Inc. Transaction History